• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Peak Flow Feedback Intervention Improves Underperception of Airflow Limitation in Pediatric Asthma: A Randomized Clinical Trial.峰值流量反馈干预改善儿童哮喘气流受限感知不足:一项随机临床试验。
Ann Am Thorac Soc. 2025 Mar;22(3):403-415. doi: 10.1513/AnnalsATS.202406-637OC.
2
Digital interventions to improve adherence to maintenance medication in asthma.数字干预措施以提高哮喘维持药物治疗的依从性。
Cochrane Database Syst Rev. 2022 Jun 13;6(6):CD013030. doi: 10.1002/14651858.CD013030.pub2.
3
Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.对于患有持续性哮喘的成人和青少年,在吸入性糖皮质激素中添加抗白三烯药物。
Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD010347. doi: 10.1002/14651858.CD010347.pub2.
4
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease.用于非甾体抗炎药(NSAID)诱发的呼吸道疾病的口服和鼻内阿司匹林脱敏疗法。
Cochrane Database Syst Rev. 2025 Jan 7;1(1):CD013476. doi: 10.1002/14651858.CD013476.pub2.
5
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.抗氧化剂预防杜氏肌营养不良症和进行性呼吸功能下降患者的呼吸功能下降。
Cochrane Database Syst Rev. 2021 Dec 1;12(12):CD013720. doi: 10.1002/14651858.CD013720.pub3.
6
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.抗氧化剂预防杜氏肌营养不良和进行性呼吸功能下降患者的呼吸功能下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013720. doi: 10.1002/14651858.CD013720.pub2.
7
Interventions to improve adherence to inhaled steroids for asthma.改善哮喘患者吸入性糖皮质激素依从性的干预措施。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD012226. doi: 10.1002/14651858.CD012226.pub2.
8
Mobile phone messaging for facilitating self-management of long-term illnesses.利用手机短信促进慢性病自我管理。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007459. doi: 10.1002/14651858.CD007459.pub2.
9
Exhaled nitric oxide levels to guide treatment for children with asthma.呼出一氧化氮水平用于指导儿童哮喘治疗。
Cochrane Database Syst Rev. 2016 Nov 9;11(11):CD011439. doi: 10.1002/14651858.CD011439.pub2.
10
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.吸入性皮质类固醇与色甘酸钠用于儿童和成人哮喘患者的比较
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003558. doi: 10.1002/14651858.CD003558.pub2.

本文引用的文献

1
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes.哮喘患儿的症状感知改变与较差的童年机会和不良结局有关。
J Allergy Clin Immunol Pract. 2024 Apr;12(4):983-990. doi: 10.1016/j.jaip.2023.12.022. Epub 2023 Dec 22.
2
Under-perception of airflow limitation, self-efficacy, and beliefs in older adults with asthma.老年人哮喘患者对气流受限的感知不足、自我效能感和信念。
J Psychosom Res. 2023 Jul;170:111353. doi: 10.1016/j.jpsychores.2023.111353. Epub 2023 May 3.
3
Effect of motivational interviewing on treatment adherence and self-efficacy of adolescents with asthma: A randomized controlled trial.动机性访谈对青少年哮喘患者治疗依从性和自我效能的影响:一项随机对照试验。
Nurs Open. 2023 Jul;10(7):4373-4383. doi: 10.1002/nop2.1679. Epub 2023 Mar 17.
4
A Pilot Randomized Controlled Trial of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma.一项改善老年哮喘患者肺功能认知的干预措施的试点随机对照试验。
Am J Respir Crit Care Med. 2023 Feb 15;207(4):487-490. doi: 10.1164/rccm.202206-1132LE.
5
Asthma Surveillance - United States, 2006-2018.哮喘监测 - 美国,2006-2018 年。
MMWR Surveill Summ. 2021 Sep 17;70(5):1-32. doi: 10.15585/mmwr.ss7005a1.
6
Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial.利用移动健康改善青少年早期的哮喘自我管理:一项先导随机对照试验。
J Adolesc Health. 2021 Dec;69(6):1032-1040. doi: 10.1016/j.jadohealth.2021.06.011. Epub 2021 Jul 15.
7
The Impact of Motivational Interview on Self-Efficacy, Beliefs About Medicines and Medication Adherence Among Adolescents with Asthma: A Randomized Controlled Trial.动机性访谈对哮喘青少年自我效能感、药物信念和用药依从性的影响:一项随机对照试验。
J Pediatr Nurs. 2021 Sep-Oct;60:116-122. doi: 10.1016/j.pedn.2021.04.020. Epub 2021 Apr 28.
8
Patterns of Asthma Medication Use across the Transition to High School.哮喘药物使用模式在高中过渡期间的变化。
J Pediatr Psychol. 2021 Jun 3;46(5):578-587. doi: 10.1093/jpepsy/jsab001.
9
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.2020 年哮喘管理指南重点更新:国家哮喘教育和预防计划协调委员会专家小组工作组的报告。
J Allergy Clin Immunol. 2020 Dec;146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003.
10
Developing and evaluating ASTHMAXcel adventures: A novel gamified mobile application for pediatric patients with asthma.开发和评估 ASTHMAXcel 冒险:一种用于哮喘儿童患者的新型游戏化移动应用程序。
Ann Allergy Asthma Immunol. 2020 Nov;125(5):581-588. doi: 10.1016/j.anai.2020.07.018. Epub 2020 Jul 22.

峰值流量反馈干预改善儿童哮喘气流受限感知不足:一项随机临床试验。

Peak Flow Feedback Intervention Improves Underperception of Airflow Limitation in Pediatric Asthma: A Randomized Clinical Trial.

作者信息

Feldman Jonathan M, Rastogi Deepa, Warman Karen, Serebrisky Denise, Arcoleo Kimberly

机构信息

Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York.

Division of Academic General Pediatrics, and.

出版信息

Ann Am Thorac Soc. 2025 Mar;22(3):403-415. doi: 10.1513/AnnalsATS.202406-637OC.

DOI:10.1513/AnnalsATS.202406-637OC
PMID:39454196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11892664/
Abstract

Underperception of asthma symptoms is associated with poor asthma outcomes. We assessed the effects of a behavioral intervention for improving perception of airflow limitation and asthma outcomes. A two-arm randomized controlled trial compared peak expiratory flow (PEF) feedback versus supportive counseling. Latino and Black adolescents with asthma ages 10-17 years old and caregivers were recruited from hospitals in the Bronx, New York. PEF feedback sessions reviewed accuracy of PEF guesses and medication adherence data and targeted behavior change using motivational interviewing and problem-solving skills training. The supportive counseling group received emotional support related to asthma. Both groups received three sessions across 6 weeks. All participants were blinded to PEF while guessing PEF before intervention and at 1, 6, and 12-month follow-up. Children in the PEF feedback group saw actual PEF after guesses were locked in during the 6-week intervention. Participants and assessors were blinded to group assignment. The primary outcome was underperception of airflow limitation (divergence between actual PEF and guesses) on home spirometers. Secondary outcomes included daily PEF and forced expiratory volume in 1 second (FEV), inhaled corticosteroid adherence measured by electronic monitors, Asthma Control Test, and emergency health care use for asthma. The sample comprised 354 children (mean = 13.2 ± 2.2 yr; 62% Latino, 38% Black) and caregivers. The PEF feedback group ( = 153 analyzed) demonstrated greater improvements at 1-month follow-up on underperception of airflow limitation (difference-in-differences, -12.64; 95% confidence interval [CI], -17.54 to -7.74), percent personal best PEF (9.89; 95% CI, 7.13 to 12.65), percent predicted FEV (4.93; 95% CI, 0.95 to 8.90), and inhaled corticosteroid adherence (16.02; 95% CI, 7.15 to 24.89) compared with the supportive counseling group ( = 152 analyzed). At 12-month follow-up, the PEF feedback group maintained improvements on underperception of airflow limitation (-13.87; 95% CI, -19.03 to -8.71), maintained higher percentage personal best PEF (14.23; 95% CI, 11.37 to 17.08) and percent predicted FEV (5.62; 95% CI, 1.56 to 9.67), and had smaller declines in inhaled corticosteroid adherence (17.51; 95% CI, 7.12 to 27.89) versus before intervention than the supportive counseling group. No between-group differences existed for asthma control or health care use. The efficacy and sustainability of PEF feedback was established in improving children's perception of airflow limitation, pulmonary function, and medication adherence. Clinical trial registered with www.clinicaltrials.gov (NCT02702687).

摘要

哮喘症状感知不足与哮喘不良预后相关。我们评估了一种行为干预对改善气流受限感知及哮喘预后的效果。一项双臂随机对照试验比较了呼气峰值流速(PEF)反馈与支持性咨询。从纽约布朗克斯区的医院招募了10至17岁患有哮喘的拉丁裔和黑人青少年及其照顾者。PEF反馈环节回顾了PEF猜测的准确性和药物依从性数据,并运用动机访谈和解决问题技能培训来针对性地改变行为。支持性咨询组接受与哮喘相关的情感支持。两组均在6周内接受三次干预。在干预前以及1个月、6个月和12个月随访时,所有参与者在猜测PEF时均对PEF数值不知情。在为期6周的干预期间,当猜测被锁定后,PEF反馈组的儿童会看到实际的PEF数值。参与者和评估者对分组情况不知情。主要结局是家庭肺量计上气流受限感知不足(实际PEF与猜测值之间的差异)。次要结局包括每日PEF和1秒用力呼气容积(FEV)、通过电子监测仪测量的吸入糖皮质激素依从性、哮喘控制测试以及哮喘的紧急医疗使用情况。样本包括354名儿童(平均年龄=13.2±2.2岁;62%为拉丁裔,38%为黑人)及其照顾者。PEF反馈组(153例纳入分析)在1个月随访时,在气流受限感知不足方面(差异差值为-12.64;95%置信区间[CI],-17.54至-7.74)、个人最佳PEF百分比(9.89;95%CI,7.13至12.65)、预计FEV百分比(4.93;95%CI,0.95至8.90)以及吸入糖皮质激素依从性(16.02;95%CI,7.15至24.89)方面,与支持性咨询组(152例纳入分析)相比有更大改善。在12个月随访时,PEF反馈组在气流受限感知不足方面仍保持改善(-13.87;95%CI,-19.03至-8.71),保持较高的个人最佳PEF百分比(14.23;95%CI,11.37至17.08)和预计FEV百分比(5.62;95%CI,1.56至9.67),并且与支持性咨询组相比,吸入糖皮质激素依从性相对于干预前的下降幅度更小(17.51;95%CI,7.12至27.89)。在哮喘控制或医疗使用方面,两组之间没有差异。PEF反馈在改善儿童对气流受限的感知、肺功能和药物依从性方面的有效性和可持续性得到了证实。该临床试验已在www.clinicaltrials.gov注册(NCT02702687)。